Glycolysis regulates KRAS plasma membrane localization and function through defined glycosphingolipids.

Area of Science:

• Cell Biology
• Cancer Metabolism
• Molecular Oncology

Background:

• Oncogenic KRAS drives the Warburg effect, a metabolic shift towards aerobic glycolysis.
• The precise role of Warburg effect products beyond ATP and biomass is not fully understood.

Purpose of the Study:

• To investigate the link between KRAS oncogenic function and the Warburg effect.
• To explore the role of glycosphingolipids in KRAS plasma membrane localization and oncogenesis.

Main Methods:

• High-resolution imaging techniques.
• Genetic manipulation of glycosphingolipid synthesis.
• Analysis of KRAS localization and oncogenic activity in pancreatic cancer models.

Main Results:

• Increased glycolytic flux supports glycosphingolipid biosynthesis, crucial for KRAS plasma membrane localization.
• Specific glycosphingolipids (GM3, SM4) are required for KRAS localization and function.
• Oncogenic KRAS upregulates these glycosphingolipids, and their depletion inhibits KRAS-driven oncogenesis.
• Glycolysis is essential for KRAS spatial organization at the plasma membrane.

Conclusions:

• The Warburg effect regulates KRAS function via glycosphingolipid synthesis, extending its role beyond energy production.
• A positive feedback loop exists between KRAS signaling and glycosphingolipid synthesis.
• This loop represents a potential therapeutic vulnerability in pancreatic cancer.